Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-10-29 00:00:00 ET · period of report 2024-10-07 · accession 0001628280-24-044118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-29 | 2024-10-07 | LFCR | Lake Ryan David | CFO | M - OptEx | — | +75.0K | 337.5K | +29% | — | |
| 2024-10-29 | 2024-10-07 | LFCR | Lake Ryan David | CFO | F - Tax | $5.09 | -34.1K | 303.4K | -10% | -$173.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-07 | M | A | 75,000 | — | 337,500 | D | — | — | (F1) The performance-based restricted stock units vested based on the Issuer's achievement of a stock price milestone. (F2) The performance-based restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Common | Common Stock | 2024-10-07 | F | D | 34,138 | $5.09 | 303,362 | D | — | — |